Literature DB >> 21698354

Fetal liver cell transplantation as a potential alternative to whole liver transplantation?

Michael Oertel1.   

Abstract

Because organ shortage is the fundamental limitation of whole liver transplantation, novel therapeutic options, especially the possibility of restoring liver function through cell transplantation, are urgently needed to treat end-stage liver diseases. Groundbreaking in vivo studies have shown that transplanted hepatocytes are capable of repopulating the rodent liver. The two best studied models are the urokinase plasminogen activator (uPA) transgenic mouse and the fumarylacetoacetate hydrolase (FAH)-deficient mouse, in which genetic modifications of the recipient liver provide a tissue environment in which there is extensive liver injury and selection pressure favoring the proliferation and survival of transplanted hepatocytes. Because transplanted hepatocytes do not significantly repopulate the (near-)normal liver, attention has been focused on finding alternative cell types, such as stem or progenitor cells, that have a higher proliferative potential than hepatocytes. Several sources of stem cells or stem-like cells have been identified and their potential to repopulate the recipient liver has been evaluated in certain liver injury models. However, rat fetal liver stem/progenitor cells (FLSPCs) are the only cells identified to date that can effectively repopulate the (near-)normal liver, are morphologically and functionally fully integrated into the recipient liver, and remain viable long-term. Even though primary human fetal liver cells are not likely to be routinely used for clinical liver cell repopulation in the future, using or engineering candidate cells exhibiting the characteristics of FLSPCs suggests a new direction in developing cell transplantation strategies for therapeutic liver replacement. This review will give a brief overview concerning the existing animal models and cell sources that have been used to restore normal liver structure and function, and will focus specifically on the potential of FLSPCs to repopulate the liver.

Entities:  

Mesh:

Year:  2011        PMID: 21698354     DOI: 10.1007/s00535-011-0427-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  63 in total

1.  Engulfment is required for cell competition.

Authors:  Wei Li; Nicholas E Baker
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

2.  Characterization and enrichment of fetal rat hepatoblasts by immunoadsorption ("panning") and fluorescence-activated cell sorting.

Authors:  S H Sigal; S Brill; L M Reid; I Zvibel; S Gupta; D Hixson; R Faris; P A Holst
Journal:  Hepatology       Date:  1994-04       Impact factor: 17.425

3.  Isolation, characterization and culture of Thy1-positive cells from fetal rat livers.

Authors:  Zvibel Isabel; Bronstein Miri; Hubel Einav; Bar-Lev Ella; Halpern Zamir; Oren Ran
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Intrasplenic fetal rat hepatic tissue isotransplantation.

Authors:  H Ebata; M Mito
Journal:  Transplantation       Date:  1985-01       Impact factor: 4.939

5.  Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity.

Authors:  Dirk Nierhoff; Atsushi Ogawa; Michael Oertel; Yuan-Qing Chen; David A Shafritz
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

6.  Maturation-dependent changes in the regulation of liver-specific gene expression in embryonal versus adult primary liver cultures.

Authors:  S Brill; I Zvibel; L M Reid
Journal:  Differentiation       Date:  1995-09       Impact factor: 3.880

7.  Characterization of cell types during rat liver development.

Authors:  Henning C Fiegel; Jonas J h Park; Michael V Lioznov; Andreas Martin; Stefan Jaeschke-Melli; Peter M Kaufmann; Boris Fehse; Axel R Zander; Dietrich Kluth
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

8.  Identification of bipotential progenitor cells in human liver development.

Authors:  Y Haruna; K Saito; S Spaulding; M A Nalesnik; M A Gerber
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

9.  Hepatocyte differentiation initiates during endodermal-mesenchymal interactions prior to liver formation.

Authors:  S Cascio; K S Zaret
Journal:  Development       Date:  1991-09       Impact factor: 6.868

10.  Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver.

Authors:  Atsushi Suzuki; Y W Zheng; Shin Kaneko; Masafumi Onodera; Katashi Fukao; Hiromitsu Nakauchi; Hideki Taniguchi
Journal:  J Cell Biol       Date:  2002-01-07       Impact factor: 10.539

View more
  16 in total

1.  Bioengineered kidneys: new sights on a distant horizon.

Authors:  Christoph Kuppe; Katja Berger; Bart Smeets
Journal:  Int Urol Nephrol       Date:  2013-10-05       Impact factor: 2.370

2.  Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.

Authors:  Tanuja L Gutti; Jaclyn S Knibbe; Edward Makarov; Jinjin Zhang; Govardhana R Yannam; Santhi Gorantla; Yimin Sun; David F Mercer; Hiroshi Suemizu; James L Wisecarver; Natalia A Osna; Tatiana K Bronich; Larisa Y Poluektova
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

Review 3.  Perspectives on whole-organ assembly: moving toward transplantation on demand.

Authors:  Alejandro Soto-Gutierrez; Jason A Wertheim; Harald C Ott; Thomas W Gilbert
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

Review 4.  Cellular therapy and bioartificial approaches to liver replacement.

Authors:  Jason A Wertheim; Pedro M Baptista; Alejandro Soto-Gutierrez
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

5.  Immortalization of Human Fetal Hepatocyte by Ectopic Expression of Human Telomerase Reverse Transcriptase, Human Papilloma Virus (E7) and Simian Virus 40 Large T (SV40 T) Antigen Towards Bioartificial Liver Support.

Authors:  Shibashish Giri; Augustinus Bader
Journal:  J Clin Exp Hepatol       Date:  2014-09-18

6.  Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.

Authors:  Mithun Sharma; Padaki Nagaraja Rao; Mitnala Sasikala; Mamata Reddy Kuncharam; Chimpa Reddy; Vardaraj Gokak; Bpss Raju; Jagdeesh R Singh; Piyal Nag; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

7.  Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytes.

Authors:  Mladen I Yovchev; Joseph Locker; Michael Oertel
Journal:  J Hepatol       Date:  2016-02-05       Impact factor: 25.083

8.  A Convenient and Efficient Method to Enrich and Maintain Highly Proliferative Human Fetal Liver Stem Cells.

Authors:  Xuan Guo; Shu Wang; Ya-ling Dou; Xiang-fei Guo; Zhao-li Chen; Xin-wei Wang; Zhi-qiang Shen; Zhi-gang Qiu; Min Jin; Jun-wen Li
Journal:  Rejuvenation Res       Date:  2015-06-10       Impact factor: 4.663

Review 9.  Cellular therapy for liver disease.

Authors:  Robert C Huebert; Jorge Rakela
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

10.  Repopulation of the fibrotic/cirrhotic rat liver by transplanted hepatic stem/progenitor cells and mature hepatocytes.

Authors:  Mladen I Yovchev; Yuhua Xue; David A Shafritz; Joseph Locker; Michael Oertel
Journal:  Hepatology       Date:  2013-11-18       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.